Paladin and Nycomed Enter Into Canadian Co-Promotion Agreement for Tridural(TM) Once-Daily Tramadol Product (CCNMatthews via Yahoo! Finance)

MONTREAL, QUEBEC-- - Paladin Labs Inc. and Nycomed Canada Inc., a subsidiary of Nycomed today announced that the companies have entered into a Canadian Co-Promotion Agreement for Tridural once-daily tramadol.

[News Source]